Raymond James & Associates’s Blueprint Medicines BPMC Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$1.56M Buy
16,898
+3,348
+25% +$310K ﹤0.01% 2384
2024
Q2
$1.46M Buy
13,550
+4,215
+45% +$454K ﹤0.01% 2343
2024
Q1
$886K Sell
9,335
-1,357
-13% -$129K ﹤0.01% 2657
2023
Q4
$986K Sell
10,692
-8,755
-45% -$808K ﹤0.01% 2516
2023
Q3
$977K Sell
19,447
-10,288
-35% -$517K ﹤0.01% 2457
2023
Q2
$1.88M Buy
29,735
+14,639
+97% +$925K ﹤0.01% 2084
2023
Q1
$679K Buy
15,096
+819
+6% +$36.8K ﹤0.01% 2705
2022
Q4
$625K Sell
14,277
-17,156
-55% -$752K ﹤0.01% 2725
2022
Q3
$2.07M Buy
31,433
+2,551
+9% +$168K ﹤0.01% 1936
2022
Q2
$1.46M Sell
28,882
-2,683
-8% -$136K ﹤0.01% 2197
2022
Q1
$2.02M Buy
31,565
+4,945
+19% +$316K ﹤0.01% 2119
2021
Q4
$2.85M Buy
26,620
+6,520
+32% +$698K ﹤0.01% 1922
2021
Q3
$2.07M Buy
20,100
+2,087
+12% +$215K ﹤0.01% 2074
2021
Q2
$1.58M Sell
18,013
-234
-1% -$20.6K ﹤0.01% 2267
2021
Q1
$1.77M Sell
18,247
-15,944
-47% -$1.55M ﹤0.01% 2098
2020
Q4
$3.84M Sell
34,191
-3,787
-10% -$425K ﹤0.01% 1479
2020
Q3
$3.52M Buy
37,978
+6,025
+19% +$559K ﹤0.01% 1411
2020
Q2
$2.49M Buy
31,953
+2,391
+8% +$186K ﹤0.01% 1591
2020
Q1
$1.73M Buy
29,562
+5,248
+22% +$307K ﹤0.01% 1656
2019
Q4
$1.95M Buy
24,314
+15,546
+177% +$1.25M ﹤0.01% 1838
2019
Q3
$644K Buy
8,768
+741
+9% +$54.4K ﹤0.01% 2479
2019
Q2
$757K Sell
8,027
-2,002
-20% -$189K ﹤0.01% 2370
2019
Q1
$803K Sell
10,029
-638
-6% -$51.1K ﹤0.01% 2328
2018
Q4
$575K Sell
10,667
-69
-0.6% -$3.72K ﹤0.01% 2456
2018
Q3
$838K Buy
+10,736
New +$838K ﹤0.01% 2361
2018
Q2
Sell
-2,556
Closed -$234K 3464
2018
Q1
$234K Sell
2,556
-448
-15% -$41K ﹤0.01% 3036
2017
Q4
$227K Sell
3,004
-133
-4% -$10.1K ﹤0.01% 2964
2017
Q3
$219K Buy
+3,137
New +$219K ﹤0.01% 2967